We are developing two main businesses with our unique basic technology "SENTAN platform", which converts all compounds into nano/microparticles. One is a drug development business for minimally invasive medical treatment that reduces the undesirable impact on the patient's body as much as possible, and the other is a preventive medicine business for the realization of a healthy and long-lived society. It is a business structure that leads to the stable growth of the entire company by making the best use of both business characteristics and complementing each other.

Having a preventive medicine business that boasts stable demand allows us to invest in the growing drug discovery business and realize medium- to long-term business expansion. In the future, we will manufacture the formulations developed with our platform technology at our own GMP factory and aim to create an organization that completes in-house the whole process from development to manufacturing. Our mission is to bring innovation to the pharmaceutical industry by shortening the lead time from drug discovery and development until launch and raising the potential of pharmaceutical compounds through the "SENTAN platform".